What are the major opportunities in the Oncology Molecular Diagnostics market? What are the strategies for the Oncology Molecular Diagnostics market?

For detailed insights on the major opportunities and strategies in the Oncology Molecular Diagnostics market, Read More

How does the Oncology Molecular Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Oncology Molecular Diagnostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Oncology Molecular Diagnostics market growth? SWOT analysis of the Oncology Molecular Diagnostics market.

For detailed insights on the key dynamics influencing the Oncology Molecular Diagnostics market growth and SWOT analysis of the Oncology Molecular Diagnostics industry, Read More

Oncology Molecular Diagnostics Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Oncology Molecular Diagnostics Market Report 2026

Name: Oncology Molecular Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Instruments, Reagents, Other Products), By Technology (Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips And Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies), By End User (Hospitals, Diagnostic Centers, Academic And Research Institutes, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Oncology Molecular Diagnostics Market Overview

• Oncology Molecular Diagnostics market size has reached to $5.65 billion in 2025

• Expected to grow to $10.13 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%

• Growth Driver: Rising Demand For Personalized Medicine Driving Growth In The Oncology Molecular Diagnostics Market

• Market Trend: Revolutionizing Oncology Molecular Diagnostics Through Advanced Genomics Technology

• North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Oncology Molecular Diagnostics Market?

The oncology molecular diagnostics refers to a procedure for diagnosing cancers and related services. Molecular diagnostics are tests that diagnose genetic information, proteins, or related molecules and provide health or disease information.

The main products in oncology molecular diagnostics market are instruments, reagents, and others. The oncology molecular diagnostics instruments are used for diagnosing cancer. The various technologies involved are polymerase chain reaction (PCR), in-situ hybridization (ISH), isothermic nucleic acid amplification technology (INNAT), chips and microarrays, sequencing, mass spectroscopy, transcription-mediated amplification (TMA), and others. These are used by various end-users, such as hospitals, diagnostic centers, academic and research institutes, and others.

Oncology Molecular Diagnostics market report bar graph

What Is The Oncology Molecular Diagnostics Market Size and Share 2026?

The oncology molecular diagnostics market size has grown rapidly in recent years. It will grow from $5.65 billion in 2025 to $6.34 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing cancer prevalence, adoption of PCR and sequencing, oncology research funding, hospital diagnostic expansion, regulatory approvals for molecular tests.

What Is The Oncology Molecular Diagnostics Market Growth Forecast?

The oncology molecular diagnostics market size is expected to see rapid growth in the next few years. It will grow to $10.13 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to precision oncology adoption, liquid biopsy advancements, personalized treatment demand, AI-driven data interpretation, emerging market penetration. Major trends in the forecast period include growth in companion diagnostics, rising use of liquid biopsy, expansion of biomarker-based testing, increasing cancer screening programs, demand for early and accurate cancer detection.

Book your 30 minutes free consultation with our research experts

Global Oncology Molecular Diagnostics Market Segmentation

1) By Product: Instruments, Reagents, Other Products

2) By Technology: Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips And Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies

3) By End User: Hospitals, Diagnostic Centers, Academic And Research Institutes, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Platforms, Fluorescence In Situ Hybridization (FISH) Instruments

2) By Reagents: DNA And RNA Extraction Kits, PCR Reagents And Kits, NGS Library Preparation Kits, Diagnostic Assay Reagents

3) By Other Products: Software For Data Analysis And Interpretation, Quality Control And Calibration Products, Consumables, For Molecular Testing, Biomarkers For Oncology Testing

What Is The Driver Of The Oncology Molecular Diagnostics Market?

The increasing demand for personalized medicine is expected to propel the growth of the oncology molecular diagnostics market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and drug therapies to the individual patient. Oncology molecular diagnostics are instrumental in the era of personalized medicine for cancer patients as they provide customized treatment plans, optimized drug selection, and more precise, effective, and individualized treatment strategies, ultimately improving patient outcomes and quality of life. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the oncology molecular diagnostics industry.

Key Players In The Global Oncology Molecular Diagnostics Market

Major companies operating in the oncology molecular diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc., Guardant Health AMEA, Veracyte Inc., Adaptive Biotechnologies Corp., Foundation Medicine Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Genomic Health Inc.

Global Oncology Molecular Diagnostics Market Trends and Insights

Major companies operating in the oncology molecular diagnostics market are focusing on advancing genomics technologies such as next-generation cancer genome sequencing, computational analytics, and innovative tumor modeling to improve early cancer detection, mutation identification, and personalized treatment strategies. These advancements enhance diagnostic precision, reduce turnaround times, and support the growing demand for localized, high-accuracy molecular testing. For instance, in May 2024, OncoHelix-CoLab, a Canada-based precision oncology provider specializing in genomic and immunologic profiling, advanced molecular diagnostics, and immune-profile testing, launched a state-of-the-art laboratory at Burjeel Medical City in the UAE. Developed through a collaboration between Burjeel Holdings and OncoHelix, the facility strengthens regional diagnostic capabilities by enabling complex molecular and immunology tests to be conducted locally rather than sent abroad. Its specialized offerings include advanced assays for multiple cancers, such as prostate cancer, supported through partnerships like its collaboration with Nanostics for the ClarityDX Prostate test.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Oncology Molecular Diagnostics Market?

In June 2023, INEX Innovate Pte Ltd, a Singapore based molecular diagnostic technology company, acquired Yourgene Health (Taiwan) Co., Ltd. for an undisclosed amount. With this acquisition, INEX Innovate’s aim is to enhance INEX's capabilities in fetal health, oncology research and development, and bioinformatics. Yourgene Health is a Taiwan based genomics company, an international molecular diagnostics group that is extending its genetic testing to include oncology.

Regional Outlook

North America was the largest region in the oncology molecular diagnostics market in 2025. Western Europe was the second largest region in the global oncology molecular diagnostics market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Oncology Molecular Diagnostics Market?

The oncology molecular diagnostics market includes revenues earned by oncology molecular diagnostics tools and kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oncology Molecular Diagnostics Market Report 2026?

The oncology molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncology molecular diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Oncology Molecular Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$6.34 billion
Revenue Forecast In 2035	$10.13 billion
Growth Rate	CAGR of 12.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Technology, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc., Guardant Health AMEA, Veracyte Inc., Adaptive Biotechnologies Corp., Foundation Medicine Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Genomic Health Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Oncology Molecular Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Oncology Molecular Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Oncology Molecular Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Oncology Molecular Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.2. Major Trends

4.2.1 Growth In Companion Diagnostics

4.2.2 Rising Use Of Liquid Biopsy

4.2.3 Expansion Of Biomarker-Based Testing

4.2.4 Increasing Cancer Screening Programs

4.2.5 Demand For Early And Accurate Cancer Detection

5. Oncology Molecular Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centers

5.3 Academic Institutes

5.4 Research Laboratories

5.5 Cancer Specialty Clinics

6. Oncology Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oncology Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Oncology Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Oncology Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Oncology Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Oncology Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oncology Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oncology Molecular Diagnostics Market Segmentation

9.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Instruments, Reagents, Other Products

9.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips And Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies

9.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Centers, Academic And Research Institutes, Other End Users

9.4. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Platforms, Fluorescence In Situ Hybridization (FISH) Instruments

9.5. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA And RNA Extraction Kits, PCR Reagents And Kits, NGS Library Preparation Kits, Diagnostic Assay Reagents

9.6. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Software For Data Analysis And Interpretation, Quality Control And Calibration Products, Consumables, Biomarkers For Oncology Testing

10. Oncology Molecular Diagnostics Market Regional And Country Analysis

10.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oncology Molecular Diagnostics Market

11.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oncology Molecular Diagnostics Market

12.1. China Oncology Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oncology Molecular Diagnostics Market

13.1. India Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oncology Molecular Diagnostics Market

14.1. Japan Oncology Molecular Diagnostics Market Overview

14.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oncology Molecular Diagnostics Market

15.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oncology Molecular Diagnostics Market

16.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oncology Molecular Diagnostics Market

17.1. South Korea Oncology Molecular Diagnostics Market Overview

17.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oncology Molecular Diagnostics Market

18.1. Taiwan Oncology Molecular Diagnostics Market Overview

18.2. Taiwan Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oncology Molecular Diagnostics Market

19.1. South East Asia Oncology Molecular Diagnostics Market Overview

19.2. South East Asia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oncology Molecular Diagnostics Market

20.1. Western Europe Oncology Molecular Diagnostics Market Overview

20.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oncology Molecular Diagnostics Market

21.1. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oncology Molecular Diagnostics Market

22.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oncology Molecular Diagnostics Market

23.1. France Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oncology Molecular Diagnostics Market

24.1. Italy Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oncology Molecular Diagnostics Market

25.1. Spain Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oncology Molecular Diagnostics Market

26.1. Eastern Europe Oncology Molecular Diagnostics Market Overview

26.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oncology Molecular Diagnostics Market

27.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oncology Molecular Diagnostics Market

28.1. North America Oncology Molecular Diagnostics Market Overview

28.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oncology Molecular Diagnostics Market

29.1. USA Oncology Molecular Diagnostics Market Overview

29.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oncology Molecular Diagnostics Market

30.1. Canada Oncology Molecular Diagnostics Market Overview

30.2. Canada Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oncology Molecular Diagnostics Market

31.1. South America Oncology Molecular Diagnostics Market Overview

31.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oncology Molecular Diagnostics Market

32.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oncology Molecular Diagnostics Market

33.1. Middle East Oncology Molecular Diagnostics Market Overview

33.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oncology Molecular Diagnostics Market

34.1. Africa Oncology Molecular Diagnostics Market Overview

34.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oncology Molecular Diagnostics Market Regulatory and Investment Landscape

36. Oncology Molecular Diagnostics Market Competitive Landscape And Company Profiles

36.1. Oncology Molecular Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Oncology Molecular Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Oncology Molecular Diagnostics Market Company Profiles

36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Oncology Molecular Diagnostics Market Other Major And Innovative Companies

Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc.

38. Global Oncology Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market

40. Oncology Molecular Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Oncology Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Oncology Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Oncology Molecular Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Oncology Molecular Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Oncology Molecular Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Oncology Molecular Diagnostics Market, Supply Chain Analysis

Table 4: Global Oncology Molecular Diagnostics Market, Major Raw Material Providers

Table 5: Global Oncology Molecular Diagnostics Market, Major Resource Providers

Table 6: Global Oncology Molecular Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Oncology Molecular Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Oncology Molecular Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Oncology Molecular Diagnostics Market, Major Trends

Table 10: Global Oncology Molecular Diagnostics Market, Major End Users

Table 11: Global Oncology Molecular Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Oncology Molecular Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Oncology Molecular Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Oncology Molecular Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Oncology Molecular Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Oncology Molecular Diagnostics Market - Company Scoring Matrix

Table 97: F. Hoffmann-La Roche AG Financial Performance

Table 98: Bayer AG Financial Performance

Table 99: Thermo Fisher Scientific Inc. Financial Performance

Table 100: Abbott Laboratories Financial Performance

Table 101: Danaher Corporation Financial Performance

Table 102: Global Oncology Molecular Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Oncology Molecular Diagnostics Market, Competitive Dashboard

Table 104: Global Oncology Molecular Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Oncology Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 106: Global, Oncology Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 107: Global, Oncology Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Oncology Molecular Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Oncology Molecular Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Oncology Molecular Diagnostics Market, Supply Chain Analysis

Figure 4: Global Oncology Molecular Diagnostics Market, Major Raw Material Providers

Figure 5: Global Oncology Molecular Diagnostics Market, Major Resource Providers

Figure 6: Global Oncology Molecular Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Oncology Molecular Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Oncology Molecular Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Oncology Molecular Diagnostics Market, Major Trends

Figure 10: Global Oncology Molecular Diagnostics Market, Major End Users

Figure 11: Global Oncology Molecular Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Oncology Molecular Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Oncology Molecular Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Oncology Molecular Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Oncology Molecular Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Oncology Molecular Diagnostics Market - Company Scoring Matrix

Figure 97: F. Hoffmann-La Roche AG Financial Performance

Figure 98: Bayer AG Financial Performance

Figure 99: Thermo Fisher Scientific Inc. Financial Performance

Figure 100: Abbott Laboratories Financial Performance

Figure 101: Danaher Corporation Financial Performance

Figure 102: Global Oncology Molecular Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Oncology Molecular Diagnostics Market, Competitive Dashboard

Figure 104: Global Oncology Molecular Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Oncology Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 106: Global, Oncology Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 107: Global, Oncology Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Industry Trends Show Oral Sleep Apnea Devices Market Set to Expand at 12.3% CAGR Until 2029

Strategic Report on Oral Syringes Market: Growth Opportunities and Emerging Challenges

Outlook for Orthopedic Market: Key Developments and Future Strategies to 2029

Future Projections: Oxygen Source Equipment Market to Reach $5.87 Billion by 2029 at 10.3% CAGR

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Diagnostic Imaging Equipment Market Report 2026 - Global Outlook – By Imaging Modality (X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipme...

Diagnostic And Monitoring Ophthalmic Devices And Equipment Market Report 2026 - Global Outlook – By Product Type (Optical Coherence Tomographers, Ophthalmic Ultrasound Imaging Systems, Fundus Cameras, Ophthalmoscopes, Ke...

Microbiology Diagnostic Devices And Equipment Market Report 2026 - Global Outlook – By Type (Laboratory Instruments, Microbiology Analyzers, Reagents And Consumables), By Reagents (Pathogen-Specific Kits, General Reagent...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Point-of-Care Diagnostics Devices And Equipment Market Report 2026 - Global Outlook – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests ki...

Medical And Diagnostic Laboratory Services Market Report 2026 - Global Outlook – By Type (Diagnostic Imaging Centers, Medical Laboratory Services), By Type of Expenditure (Public, Private), By Application (Cardiology, On...

Medical Equipment Market Report 2026 - Global Outlook – By Type (In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical ...

Frequently Asked Questions

How big is the Oncology Molecular Diagnostics Market?

The Oncology Molecular Diagnostics market was valued at $5.65 billion in 2025, increased to $6.34 billion in 2026, and is projected to reach $10.13 billion by 2030.

What is the Oncology Molecular Diagnostics market growth?

The global Oncology Molecular Diagnostics market is expected to grow at a CAGR of 12.4% from 2026 to 2035 to reach $10.13 billion by 2035.

Who are the key players in Oncology Molecular Diagnostics market?

Some Key Players in the Oncology Molecular Diagnostics market Include, F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologie

Major trend in this market includes: Revolutionizing Oncology Molecular Diagnostics Through Advanced Genomics Technology . For further insights on this market. request a sample here

North America was the largest region in the oncology molecular diagnostics market in 2025. Western Europe was the second largest region in the global oncology molecular diagnostics market report. The regions covered in the oncology molecular

Book your 30 minutes free consultation with our research experts

Contact Us